SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

AstraZenecas reported Baxfendy sales have traders questioning how quickly the new aldosterone-inhibitor class can gain coverage and commercial traction, weighing on expectations for Mineralys planned launch. Some see the early sales as a normal reimbursement ramp for a chronic treatment, while others worry that a slow launch and competition could constrain lorundrostats sales potential.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of Voceryq, a competing treatment for recurrent respiratory papillomatosis, has put pressure on Precigens PAPZIMEOS and raised concerns about competition. Traders debate the threat to Precigens sales against its first-mover and full-approval advantages, while noting Voceryqs accelerated-approval status and commercialization hurdles.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is drawing attention after Piper Sandler lowered its price target, keeping a Neutral rating while pointing to concerns that networking growth may be peaking and valuations could compress. Traders are debating whether the selloff is justified or an overreaction, with bulls pointing to continued AI-infrastructure demand and bears focused on weak price action.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,617.445403. The last known price of Zebec Network is 0.00204055 USD and is down -0.09 over the last 24 hours. It is currently trading on 133 active market(s) with $10,537,951.06 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Traders are focused on reported MoneyGram connectivity and Zebecs broader payroll and payments expansion, viewing real-world adoption and potential token demand as bullish catalysts. Others remain skeptical, pointing to weak price follow-through and questioning whether business growth will translate into sustained ZBCN usage or buybacks.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Positive Phase 3 data for Amgens IMDELLTRAImfinzi combination in small-cell lung cancer is supporting bullish attention as shares reach a fresh high, with traders also focused on the upcoming earnings report and a Sjgrens disease readout. Put-heavy options activity is being debated as possible earnings hedging rather than a clear bearish bet, alongside call buying and momentum interest.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIMs attention is centered on its higher full-year outlook, which traders link to persistently strong container freight rates and demand, boosting expectations for earnings and dividends. The community is also debating whether Hapag-Lloyds acquisition can clear Israeli regulatory objections, with some favoring a sale and others preferring standalone cash generation and dividends.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a 52-week high ahead of the expected Q3 report has traders focused on BRIUMVIs sales momentum, while unconfirmed buyout speculation and call-heavy options activity add to the buzz. The community is split on whether the rally reflects earnings positioning and potential short covering or anticipation of a deal; no buyout has been confirmed.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devons agreed sale of its Eagle Ford assets to Crescent is driving attention, following earlier speculation about asset divestitures and pressure to streamline the company after its Coterra merger. Traders are divided on whether the sale improves focus and capital allocation, with some questioning why the shares have not responded more strongly.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders react to a sharp tech-led Nasdaq selloff and falling futures, with worries about AI spending returns and disappointing tech results reinforcing bearish bets. Many are buying or holding SQQQ as a hedge, while others warn that the leveraged ETF can reverse quickly; separate Iran-deal chatter remains unverified and contested.

3M Co. is a technology company, which engages in manufacturing industrial, safety, and consumer products. It operates through the following segments: Safety and Industrial, Transportation and Electronics, Consumer, and Corporate. The Safety and Industrial segment consists of personal safety, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules. The Transportation and Electronics segment includes electronics, automotive and aerospace, commercial solutions, advanced materials, and transportation safety. The Consumer segment covers consumer healthcare, home care, home improvement, and stationery and office products, such as consumer bandages, braces, supports, respirators, cleaning products, retail abrasives, picture hanging, and consumer air quality solutions. The Corporate segment refers to special items and other corporate expenses. The company was founded by Henry S. Bryan, Hermon W. Cable, John Dwan, William A. McGonagle, and J. Danley Budd in 1902 and is headquartered in St. Paul, MN.

3M Co.

3Ms earnings beat and raised outlook, alongside its expanded Amazon data-center partnership, are driving attention. Bulls see the deal as a growth opportunity, while skeptics note that Amazons purchase threshold is conditional and call the rally overdone, with bearish traders discussing puts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

WOOF or ARHS: Which Is the Better Value Stock Right Now?

WOOF vs. ARHS: Which Stock Is the Better Value Option?

Best Growth Stocks to Buy for October 26th

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 26th, 2026.

Best Growth Stocks to Buy for October 23rd

UGP, WOOF and MNDY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 23, 2026

Best Growth Stocks to Buy for October 21st

WOOF, ASAIY and BP made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 21, 2026.

Best Growth Stocks to Buy for October 15th

WOOF, FIVE, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13,52026.

Paws on the Nice List: Petco Unveils "Never Naughty, Always Nice" Holiday Campaign Ft. Hundreds of Gifts at $10 or Less, Free Santa Photos and In-Store Events

Paws on the Nice List: Petco Unveils "Never Naughty, Always Nice" Holiday Campaign Ft. Hundreds of Gifts at $10 or Less, Free Santa Photos and In-Store Events Paws on the Nice List: Petco Unveils "Never Naughty, Always Nice" Holiday Campaign Ft. Hundreds of Gifts at $10 or Less, Free Santa Photos...

Best Growth Stocks to Buy for October 13th

WOOF, FIVE, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13, 2026.

Best Growth Stocks to Buy for October 9th

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 9th, 2026.

Best Growth Stocks to Buy for October 7th

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 7th, 2026.

Petco Health & Wellness Company, Inc. engages in the provision of pet health and wellness services. It operates across the U.S., Mexico and Puerto Rico, including a growing network, store veterinary hospitals, and offer a complete online resource for pet health and wellness. The firm offers grooming, as well as in-store and online training. The company was founded in 1965 and is headquartered in San Diego, CA.

Petco Health and Wellness Co Inc - Ordinary Shares - Class A

FIVE, WOOF Stocks Rise Premarket: Five Below And Petco Get Fresh Wall Street Price Target Boosts Ahead Of Earnings 

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Deutsche Bank increased Five Below’s price target to $334 from $318 and kept its Buy rating.</li><li>Evercore ISI raised Petco’s price target to $4 from $3.50 but maintained its In Line rating.</li><li>Five Below has gained about 30% this year as shoppers seek value, while Petco has fallen 8% due to weaker discretionary spending.</li></ul><p>Five Below Inc. (FIVE) and Petco Health and Wellness Co. (WOOF) stocks rose premarket on Wednesday as investors responded to fresh Wall Street price target increases ahead of its fiscal second-quarter (Q2) 2026 earnings. Deutsche Bank raised its price target for Five Below while Evercore ISI lifted Petco’s price target.&nbsp;</p><p><a href="https://stocktwits.com/symbol/FIVE">Five Below stock</a> traded over 1% higher in Wednesday’s premarket, while&nbsp;<a href="https://stocktwits.com/symbol/WOOF">Petco Health stock</a> climbed over 3%.&nbsp;</p><h2 class="st-heading-2">Five Below, Petco In Focus&nbsp;</h2><p>Deutsche Bank analyst Krisztina Katai increased the price target for Five Below to $334 from $318 while maintaining a ‘Buy’ rating. The move suggests the analyst sees 36% additional upside from the discount retailer’s last closing price.&nbsp;</p><p>Evercore ISI also raised its price target for Petco Health and Wellness to $4 from $3.50. The firm kept its ‘In Line’ rating, signaling a more measured outlook on the pet retailer.</p><p>The updates put the two retailers in notably different positions. Deutsche Bank remains constructive on Five Below, while Evercore ISI’s unchanged In Line stance indicates that the higher Petco target does not necessarily reflect a stronger bullish view.</p><h2 class="st-heading-2">Five Below Rides Value-Shopping, Petco Faces Debt Concerns</h2><p>Five Below has gained about 30% this year, outperforming specialty retail peers including Ulta Beauty (ULTA), Dick's Sporting Goods (DKS) and Williams-Sonoma (WSM) as inflation pressures push more middle- and upper-income consumers toward value retailers. The company’s growth has been fueled by strong sales and earnings, along with its “Five Beyond” concept, which adds merchandise priced above $5 and increases average spending.</p><p>The retailer is set to report its Q2 results on Sept. 2, with Wall Street expecting revenue of about $1.22 billion and EPS of $1.41, according to Fiscal.A\ai data. Investors will also look for discussion of store expansion, with Five Below targeting more than 3,500 locations, while tariff management and supply-chain improvements remain key to protecting margins.</p><p>Petco Health and Wellness is down about 8% in 2026 as customers spend less on non-essential pet items and shop more online. Demand for pet food and veterinary care remains steady, but weaker sales of toys, accessories, and premium products have hurt growth.&nbsp;</p><p>Petco is also working through significant debt and margin pressures while competing with online rival Chewy. Its debt refinancing pushed maturities to 2031, but interest costs remain a concern. Analysts see $1.49 billion in revenue and&nbsp; $0.07 EPS for Q2.&nbsp;</p><h2 class="st-heading-2">FIVE, WOOF Stocks: Retail View&nbsp;</h2><p>On Stocktwits, retail sentiment around FIVE stock improved to ‘bullish’ from ‘neutral’ territory, while sentiment around WOOF stock turned ‘neutral’ from ‘bearish’.&nbsp;</p><p>FIVE stock has surged 63% in the past year, while WOOF stock has cratered 28%.&nbsp;</p><p>Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pcg-eix-stocks-head-for-worst-week-in-a-year-as-they-reel-from-california-wildfire-reform-setback-bo-fa-turns-neutral-slashes-targets/cZsA1yNRJug">PCG, EIX Stocks Head For Worst Week In A Year As They Reel From California Wildfire Reform Setback: BoFA Turns Neutral, Slashes Targets</a></p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com</p>

Logo of the Five Below store in Roseville, Minnesota. Source: : Michael Siluk/UCG/Universal Images Group via Getty Images

Analysts’ positive views lifted Five Below and Petco stocks as investors looked at growth, value shopping, and debt concerns.

FIVE, WOOF Stocks Rise Premarket: Five Below And Petco Get Fresh Wall Street Price Target Boosts Ahead Of Earnings

Analysts’ positive views lifted Five Below and Petco stocks as investors looked at growth, value shopping, and debt concerns. 


Five Below Inc

Petco Health and Wellness Co Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

WOOF News